Reduced Gluteofemoral (subcutaneous) Fat Mass in Young Japanese Women with Family History of Type 2 Diabetes: an Exploratory Analysis
Authors
Affiliations
Limited expandability of subcutaneous adipose tissue may be characteristics of first-degree relatives of type 2 diabetes. We tested the hypothesis that family history of type 2 diabetes (FHD) may be associated with reduced peripheral fat mass. Body composition and metabolic variables were compared between 18 and 111 Japanese female collegiate athletes, and between 55 and 148 nonathletes with positive (FHD +) and negative FHD (FHD-), respectively. We had multivariate logistic regression analyses for FHD + as dependent variable in a total population.BMI averaged < 21 kg/m and did not differ between FHD + and FHD- nonathletes. Despite comparable BMI, body fat percentage and serum leptin were lower in FHD + nonathletes. This was due to lower arm and gluteofemoral fat percentage (both p = 0.02) whereas the difference in trunk fat percentage was not significant (p = 0.08). These differences were not found between two groups of athletes. FHD + women had lower HDL cholesterol despite lower BMI in a total population. Fasting insulin, serum adiponectin and high-sensitivity C-reactive protein did not differ between FHD + and FHD- athletes or nonathletes. Multivariate logistic regression analyses revealed independent associations of FHD + with BMI (odds ratio, 0.869; 95% confidential interval, 0.768-0.984; p = 0.02) and HDL cholesterol (odds ratio, 0.977; 95% confidential interval, 0.957-0.997, p = 0.02). In conclusion, FHD may be associated with reduced subcutaneous fat mass in young Japanese women, suggesting impaired adipose tissue expandability.
Minato-Inokawa S, Tsuboi-Kaji A, Honda M, Takeuchi M, Kitaoka K, Kurata M Sci Rep. 2024; 14(1):19234.
PMID: 39164380 PMC: 11336068. DOI: 10.1038/s41598-024-70396-5.
Minato-Inokawa S, Honda M, Tsuboi-Kaji A, Takeuchi M, Kitaoka K, Kurata M Sci Rep. 2024; 14(1):18590.
PMID: 39127728 PMC: 11316777. DOI: 10.1038/s41598-024-69181-1.
Minato-Inokawa S, Honda M, Tsuboi-Kaji A, Takeuchi M, Kitaoka K, Kurata M Sci Rep. 2024; 14(1):16347.
PMID: 39013950 PMC: 11252386. DOI: 10.1038/s41598-024-67184-6.
Minato-Inokawa S, Honda M, Tsuboi-Kaji A, Takeuchi M, Kitaoka K, Kurata M Metabol Open. 2024; 22:100289.
PMID: 38872905 PMC: 11169472. DOI: 10.1016/j.metop.2024.100289.
Minato-Inokawa S, Tsuboi-Kaji A, Honda M, Takeuchi M, Kitaoka K, Kurata M Diabetol Int. 2024; 15(2):270-277.
PMID: 38524930 PMC: 10959855. DOI: 10.1007/s13340-023-00689-z.